|
|
 |
|
Viewing report
|
|
|
|
Phase I/II Trial Head and Neck Cancer Data Update Call - Oncolytics Biotech, Inc., - Earnings Transcript
FactSet, June 2010
Phase I/II Trial Head and Neck Cancer Data Update Call - Oncolytics Biotech, Inc., - Earnings Transcript
Monday, June 07, 2010 01:00
Corrected Transcripts are verbatim transcripts that have been reviewed and corrected by industry-focused financial professionals. Our editors re-listen to the entire call audio and confirm and research all the terms and numbers in the call to eliminate 'inaudible,' 'indiscernible,' or 'phonetic' entries. The result is the most accurate Corrected Transcript available in the marketplace.
Coverage of a variety of event types:
- Analyst/Shareholder Meetings - Conferences and Presentations - Earnings - Guidance/Update Meetings - Sales Results - Special Events and M&A
Customers who bought this item also bought
Oncolytics Biotech Inc. - Product Pipeline Review - H2 2011
Oncolytics Biotech Inc. - Product Pipeline Review - Q4 2010
Oncolytics Biotech Inc. - Product Pipeline Review - Q4 2010
Oncolytics Biotech Inc. (ONC) - Financial and Strategic SWOT Analysis Review
Oncolytics Biotech Inc. - Product Pipeline Review - Q1 2011
REOLYSIN(R) Phase 3 Trial Results Call - Oncolytics Biotech, Inc., - Earnings Transcript
ACT Biotech, Inc. - Product Pipeline Review - H2 2011
REOLYSIN Phase 3 Program Update Call - Oncolytics Biotech, Inc., - Earnings Transcript
Welichem Biotech Inc. - Product Pipeline Review - H2 2011
GTx, Inc. - Product Pipeline Review - H2 2011
|
|
|
|
